Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Drug Insights
4 min read
A Comprehensive Review of Insulin degludec's R&D Innovations and Drug Target Mechanism
22 September 2023
This article summarized the latest R&D progress of Insulin degludec, the Mechanism of Action for Insulin degludec, and the drug target R&D trends for Insulin degludec.
Latest Hotspot
4 min read
BeiGene reports positive regulatory developments in Europe and the U.S., following the recent reacquisition of worldwide rights to TEVIMBRA®
22 September 2023
BeiGene, Ltd. revealed that TEVIMBRA®(tislelizumab) has received approval by the EC to be used as a single therapy for addressing unresectable.
Drug Insights
4 min read
Pharmaceutical Insights: Inosine's R&D Progress and its Mechanism of Action on Drug Target
22 September 2023
This article summarized the latest R&D progress of Inosine, the Mechanism of Action for Inosine, and the drug target R&D trends for Inosine.
Valuable Targets
6 min read
Analysis on the Research Progress of HIV-1 Protease Inhibitors
22 September 2023
HIV-1 protease is an enzyme that plays a crucial role in the replication of the human immunodeficiency virus (HIV-1) within the human body.
Drug Insights
4 min read
An In-depth Analysis of Pimozide's R&D Progress and Mechanism of Action on Drug Target
22 September 2023
This article summarized the latest R&D progress of Pimozide, the Mechanism of Action for Pimozide, and the drug target R&D trends for Pimozide.
Latest Hotspot
4 min read
ESSA Pharma starts Phase 2 trial of EPI-7386 with Enzalutamide for Metastatic Castration-Resistant Prostate Cancer patients
22 September 2023
ESSA Pharma Begins Phase 2 trial of Masofaniten (EPI-7386) in Combination with Enzalutamide for Patients Suffering from Metastatic Castration-Resistant Prostate Cancer.
Drug Insights
4 min read
Penicillamine: Detailed Review of its Transformative R&D Success
22 September 2023
This article summarized the latest R&D progress of Penicillamine, the Mechanism of Action for Penicillamine, and the drug target R&D trends for Penicillamine.
Valuable Targets
6 min read
Analysis on the Research Progress of GnRHR antagonists
22 September 2023
GnRH, also known as Gonadotropin-Releasing Hormone, is a decapeptide hormone secreted by the arcuate nucleus neurons in the hypothalamus.
Drug Insights
4 min read
Exploring Ibandronate sodium's Revolutionary R&D Successes
21 September 2023
This article summarized the latest R&D progress of Ibandronate sodium, the Mechanism of Action for Ibandronate sodium, and the drug target R&D trends for Ibandronate sodium.
Latest Hotspot
3 min read
FDA fast-tracks review of Merck's new WELIREG (belzutifan) drug submission for advanced kidney cancer patients
21 September 2023
FDA Prioritizes Review of Merck's Additional New Drug Submission for WELIREG® (belzutifan) for Previously Treated Patients with Advanced Renal Cell Carcinoma.
Drug Insights
4 min read
Decoding Hydroxocobalamin: A Comprehensive Study of its R&D Trends
21 September 2023
This article summarized the latest R&D progress of Hydroxocobalamin, the Mechanism of Action for Hydroxocobalamin, and the drug target R&D trends for Hydroxocobalamin.
Valuable Targets
6 min read
Analysis on the Research Progress of HSP90 inhibitors
21 September 2023
Heat shock protein 90 (HSP90) is an ATP-dependent molecular chaperone essential in eukaryotic organisms.